Ostatní
Návod 
Veracyte, Inc.
VCYT
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
3.4B
Obrat
1B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
2%
ROA
2%
PE
39
PS
5
Cena 1R
23-51
⌀ Cena
33.28
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
25-02-2026
Poslední dividenda
Profil
Společnost Veracyte, Inc. působí jako diagnostická společnost po celém světě. Společnost nabízí klasifikátor sekvencování genomu Afirma a atlas exprese, které se používají k určení pacientů s neurčitými výsledky jsou benigní, aby se zabránilo zbytečnému chirurgickému zákroku; Decipher Prostate Biopsy a Radical Prostatectomy pro diagnózu karcinomu prostaty; Prosigna Prast Cancer Assay pro diagnostiku karcinomu prsu; Percepta Genomic Sequencing Classifier a Percepta Nasal Swab Test pro diagnostiku karcinomu plic; Envisia Genomic Classifier pro diagnostiku intersticiálního plicního onemocnění, včetně idiopatické plicní fibrózy; a imunoskóre test na karcinom tlustého střeva pro diagnózu karcinomu tlustého střeva. Vyvíjí také genomický atlas Percepta, který pomáhá informovat o rozhodnutích týkajících se léčby rakoviny plic; klasifikátor Envisia, analytický systém nCounter; a test na subtypizaci lymfomu pomocí LymphMarku. Společnost Veracyte, Inc. má technologické licence a ujednání o spolupráci s firmami Johnson & Johnson, Acerta Pharma a CareDx. Společnost byla dříve známá jako Calderome, Inc. a v březnu 2008 změnila své jméno na Veracyte, Inc. Veracyte, Inc. byla založena v roce 2006 a sídlí v jižním San Francisku v Kalifornii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
824
Založení
2013-10-30
Podobné společnosti
$ 38.59
+ $ 0.22
$ 21.56
- $ 0.35
$ 31.73
- $ 0.07
$ 29.44
+ $ 0.49
$ 82.78
- $ 1.07
$ 72.35
+ $ 4.10
$ 30.79
+ $ 0.55
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 517.1 | 517.1 | 445.8 | 361.1 | 296.5 | 219.5 | 117.5 | 120.4 | 92.0 | 72.0 | 65.1 | 49.5 | 38.2 | 21.9 | 11.6 | 2.6 | |
| Cost of Revenues | 151.9 | 157.1 | 147.6 | 112.9 | 101.6 | 74.4 | 41.5 | 36.5 | 33.1 | 28.2 | 25.5 | 21.5 | 16.6 | 12.6 | 7.6 | 2.9 | |
| Gross Profit | 365.2 | 360.0 | 298.1 | 248.1 | 195.0 | 145.1 | 76.0 | 83.8 | 58.9 | 43.8 | 39.6 | 28.0 | 21.6 | 9.3 | 4.0 | -0.3 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 140.6 | 131.9 | 130.2 | 114.5 | 118.6 | 115.9 | 114.4 | 96.8 | 96.8 | 98.2 | |
| Cost of Revenues | 36.0 | 40.6 | 40.4 | 35.0 | 39.9 | 36.9 | 36.5 | 34.4 | 36.3 | 35.0 | |
| Gross Profit | 104.7 | 91.3 | 89.8 | 79.5 | 78.8 | 79.0 | 77.9 | 62.5 | 60.5 | 63.2 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 57.3 | 40.6 | 29.8 | 17.2 | 14.9 | 14.8 | 13.9 | 15.3 | 12.8 | 9.8 | 7.8 | 6.6 | 6.7 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 184.2 | 174.1 | 181.2 | 89.1 | 82.7 | 65.3 | 55.3 | 52.0 | 47.9 | 40.8 | 24.6 | 16.4 | 8.3 | |
| Depreciation & Amortization | 21.4 | 21.4 | 23.5 | 27.2 | 25.9 | 19.6 | 8.7 | 7.3 | 3.9 | 3.8 | 1.1 | 0.8 | 1.2 | 1.0 | 0.7 | 0.6 | |
| Total Operating Expenses | 318.7 | 285.9 | 282.0 | 333.9 | 236.0 | 227.0 | 111.4 | 99.0 | 81.2 | 70.3 | 68.4 | 61.5 | 50.6 | 32.5 | 23.0 | 15.0 | |
| Operating Income | 46.5 | 74.2 | 16.1 | -85.8 | -41.1 | -81.9 | -35.4 | -15.1 | -22.2 | -26.5 | -28.8 | -33.5 | -29.0 | -23.2 | -18.9 | -15.3 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 15.7 | 18.4 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 49.0 | 46.2 | ||
| Depreciation & Amortization | 5.3 | 5.3 | 5.5 | 5.4 | 6.3 | 5.9 | 5.7 | 5.6 | 5.6 | 6.3 | ||
| Total Operating Expenses | 78.7 | 68.3 | 95.0 | 76.6 | 74.6 | 67.0 | 73.3 | 67.1 | 64.8 | 64.6 | ||
| Operating Income | 25.9 | 22.9 | -5.3 | 2.9 | 4.2 | 12.0 | 4.6 | -4.7 | -4.2 | -1.4 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 9.2 | 0.0 | 11.2 | 7.3 | 2.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | -4.7 | 0.2 | 0.2 | 0.7 | 2.0 | 4.9 | 2.8 | 0.4 | 0.4 | 0.2 | 0.0 | 0.0 | |
| Other Expense | 21.7 | -5.9 | 9.6 | 9.2 | 4.7 | 0.3 | 0.5 | 2.5 | 1.2 | 0.5 | 0.2 | 0.1 | 0.1 | -2.2 | 0.3 | 0.8 | |
| IBT | 68.2 | 68.2 | 25.7 | -76.6 | -36.4 | -81.6 | -34.9 | -12.6 | -23.0 | -31.0 | -31.4 | -33.7 | -29.4 | -25.6 | -18.6 | -14.4 | |
| Income Tax Expense | 1.8 | 1.8 | 1.6 | -2.2 | 0.1 | -6.1 | 0.9 | 3.9 | 1.2 | 5.4 | 3.0 | 0.5 | -0.7 | -2.9 | 0.0 | 0.8 | |
| Net Income | 66.4 | 66.4 | 24.1 | -74.4 | -36.6 | -75.6 | -35.8 | -16.5 | -23.0 | -31.0 | -31.4 | -33.7 | -29.4 | -25.6 | -18.6 | -14.4 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 3.5 | 2.9 | 2.8 | 2.9 | 2.9 | 2.7 | 2.7 | 2.7 | 2.8 | ||
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Other Expense | 14.7 | -4.1 | 6.5 | 4.5 | -0.7 | 4.8 | 2.8 | 2.7 | 2.3 | 5.0 | ||
| IBT | 40.6 | 18.9 | 1.3 | 7.4 | 3.4 | 16.8 | 7.4 | -1.9 | -1.9 | -30.5 | ||
| Income Tax Expense | -0.5 | -0.2 | 2.2 | 0.4 | -1.7 | 1.7 | 1.6 | 0.0 | 0.0 | -2.2 | ||
| Net Income | 41.1 | 19.1 | -1.0 | 7.0 | 5.1 | 15.2 | 5.7 | -1.9 | -1.9 | -28.3 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-1.02 | $-0.51 | $-1.11 | $-0.67 | $-0.36 | $-0.62 | $-0.91 | $-1.09 | $-1.30 | $-1.36 | $-6.15 | $-1.31 | $-1.02 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-1.02 | $-0.51 | $-1.11 | $-0.67 | $-0.36 | $-0.62 | $-0.91 | $-1.09 | $-1.30 | $-1.36 | $-6.15 | $-1.31 | $-1.02 | |
| Shares Outstanding | 79.2 | 78.6 | 76.5 | 72.6 | 71.5 | 67.9 | 53.2 | 46.1 | 37.0 | 33.9 | 28.8 | 25.9 | 21.6 | 4.2 | 14.2 | 14.2 | |
| Diluted Shares Outstanding | 81.4 | 80.6 | 78.2 | 72.6 | 71.5 | 67.9 | 53.2 | 46.1 | 37.0 | 33.9 | 28.8 | 25.9 | 21.6 | 4.2 | 14.2 | 14.2 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.02 | $-0.39 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.02 | $-0.39 | ||
| Shares Outstanding | 79.2 | 78.7 | 78.2 | 78.0 | 77.6 | 77.0 | 76.5 | 74.8 | 74.8 | 73.1 | ||
| Diluted Shares Outstanding | 81.4 | 79.7 | 79.9 | 80.1 | 79.9 | 78.5 | 77.2 | 74.8 | 74.8 | 73.1 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 235.9 | 239.1 | 216.5 | 154.2 | 173.2 | 349.4 | 159.3 | 78.0 | 33.9 | 59.2 | 39.1 | 35.0 | 71.2 | 14.0 | 7.6 | |
| Short Term Investments | 0.0 | 50.4 | 0.0 | 24.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 235.9 | 289.4 | 216.5 | 178.9 | 173.2 | 349.4 | 159.3 | 78.0 | 33.9 | 59.2 | 39.1 | 35.0 | 71.2 | 14.0 | 7.6 | |
| Accounts Receivable | 50.3 | 46.5 | 40.4 | 44.0 | 41.5 | 18.5 | 19.3 | 13.2 | 12.7 | 8.8 | 3.5 | 3.1 | 1.1 | 0.6 | 0.2 | |
| Inventory | 19.3 | 21.8 | 16.1 | 14.3 | 11.2 | 4.7 | 6.8 | 3.4 | 5.3 | 3.5 | 3.8 | 3.7 | 2.6 | 1.1 | 0.3 | |
| Other Current Assets | 15.6 | 14.6 | 12.7 | 11.5 | 17.2 | 3.2 | 2.2 | 2.4 | 2.0 | 2.1 | 1.5 | 1.2 | 1.5 | 0.7 | 0.5 | |
| Total Current Assets | 321.1 | 372.3 | 285.6 | 248.6 | 243.1 | 375.7 | 187.7 | 97.0 | 53.9 | 73.6 | 47.9 | 43.3 | 76.4 | 16.4 | 8.6 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 315.6 | 219.5 | 186.1 | 239.1 | 274.1 | 235.9 | 209.2 | 209.2 | 216.5 | 202.5 | |
| Short Term Investments | 50.9 | 101.2 | 101.2 | 50.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 366.4 | 320.7 | 287.4 | 289.4 | 274.1 | 235.9 | 209.2 | 209.2 | 216.5 | 202.5 | |
| Accounts Receivable | 47.8 | 50.8 | 53.8 | 46.5 | 48.8 | 50.3 | 46.7 | 46.7 | 40.4 | 39.3 | |
| Inventory | 20.3 | 25.0 | 24.3 | 21.8 | 20.4 | 19.3 | 18.3 | 18.3 | 16.1 | 15.9 | |
| Other Current Assets | 14.6 | 18.1 | 17.8 | 14.6 | 13.6 | 15.6 | 16.2 | 16.2 | 12.7 | 13.5 | |
| Total Current Assets | 449.2 | 414.7 | 383.2 | 372.3 | 356.9 | 321.1 | 290.4 | 290.4 | 285.6 | 271.2 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 40.4 | 71.1 | 30.9 | 30.9 | 31.1 | 16.8 | 17.7 | 8.9 | 9.7 | 11.5 | 10.3 | 4.2 | 3.0 | 2.4 | 1.7 | |
| Goodwill | 752.1 | 745.8 | 703.0 | 695.9 | 707.9 | 2.7 | 2.7 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 112.5 | 102.3 | 88.6 | 174.9 | 202.7 | 59.9 | 65.0 | 12.0 | 13.1 | 14.1 | 15.2 | 16.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 1.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.3 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 7.1 | 8.5 | 6.8 | 6.2 | 2.9 | 2.0 | 2.0 | 1.7 | 0.9 | 0.7 | 0.8 | 0.3 | 0.3 | 0.2 | 0.2 | |
| Total Long-Term Assets | 913.2 | 927.8 | 829.3 | 907.8 | 944.7 | 81.5 | 87.5 | 23.7 | 24.7 | 27.4 | 27.4 | 21.5 | 3.2 | 2.7 | 1.9 | |
| Total Assets | 1,234.3 | 1,300.0 | 1,114.9 | 1,156.4 | 1,187.8 | 457.2 | 275.2 | 120.6 | 78.7 | 101.0 | 75.3 | 64.8 | 79.6 | 19.1 | 10.5 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 56.2 | 57.2 | 70.2 | 71.1 | 38.2 | 40.4 | 32.7 | 32.7 | 30.9 | 30.6 | |
| Goodwill | 767.2 | 773.3 | 754.3 | 745.8 | 762.1 | 752.1 | 753.9 | 753.9 | 703.0 | 693.2 | |
| Intangible Assets | 92.5 | 95.8 | 99.1 | 102.3 | 108.9 | 112.5 | 116.3 | 116.3 | 88.6 | 123.6 | |
| Long-Term Investments | 1.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.1 | 0.9 | 0.9 | |
| Other Long-Term Assets | 1.1 | 3.1 | 8.7 | 8.5 | 9.0 | 8.2 | 6.7 | 5.6 | 6.0 | 6.5 | |
| Total Long-Term Assets | 918.6 | 929.4 | 932.3 | 927.8 | 918.2 | 913.2 | 909.7 | 909.7 | 852.2 | 853.8 | |
| Total Assets | 1,367.8 | 1,344.1 | 1,315.4 | 1,300.0 | 1,275.0 | 1,234.3 | 1,200.1 | 1,200.1 | 1,137.8 | 1,124.9 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 12.1 | 8.6 | 12.9 | 11.9 | 12.4 | 3.1 | 2.3 | 2.5 | 3.9 | 2.4 | 5.1 | 7.4 | 5.3 | 1.9 | 0.6 | |
| Short-Term Debt | 7.2 | 7.5 | 10.2 | 4.1 | 4.8 | 1.6 | 1.4 | 1.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Liabilities | 50.9 | 60.8 | 36.1 | 44.0 | 42.4 | 11.7 | 13.7 | 9.2 | 8.2 | 9.1 | 9.6 | 9.7 | 10.1 | 7.1 | 1.3 | |
| Current Liabilities | 72.3 | 78.6 | 61.2 | 62.6 | 64.2 | 16.8 | 17.5 | 13.1 | 12.0 | 11.5 | 14.7 | 17.1 | 15.4 | 9.0 | 1.9 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 5.5 | 11.4 | 15.7 | 8.6 | 9.7 | 12.1 | 12.2 | 12.2 | 12.9 | 12.5 | |
| Short-Term Debt | 4.3 | 6.4 | 7.4 | 7.5 | 7.3 | 7.2 | 6.0 | 6.0 | 10.2 | 10.0 | |
| Other Current Liabilities | 61.9 | 57.1 | 50.3 | 60.8 | 51.3 | 50.9 | 37.3 | 37.3 | 36.1 | 32.5 | |
| Current Liabilities | 72.2 | 76.4 | 75.1 | 78.6 | 70.3 | 72.3 | 58.1 | 58.1 | 61.2 | 57.3 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 13.6 | 43.2 | 7.5 | 10.6 | 14.1 | 10.7 | 12.2 | 23.9 | 25.2 | 25.5 | 5.0 | 4.9 | 4.9 | 0.0 | 0.0 | |
| Capital Leases | 13.6 | 50.7 | 12.6 | 14.7 | 17.7 | 11.5 | 12.9 | 0.0 | 0.3 | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 1.5 | 1.2 | 0.7 | 4.5 | 5.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 101.8 | 124.1 | 70.8 | 81.2 | 91.3 | 35.9 | 35.8 | 40.9 | 41.4 | 41.5 | 24.0 | 23.5 | 23.2 | 14.2 | 1.9 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 36.2 | 44.2 | 43.1 | 43.2 | 12.4 | 13.6 | 8.1 | 8.1 | 7.5 | 8.7 | |
| Capital Leases | 0.0 | 50.6 | 50.5 | 50.7 | 19.7 | 20.7 | 14.0 | 8.1 | 7.5 | 13.7 | |
| Def. Tax Liability | 1.2 | 1.3 | 1.2 | 1.2 | 1.5 | 1.5 | 1.3 | 1.3 | 23.6 | 3.6 | |
| Total Liabilities | 110.1 | 123.0 | 120.5 | 124.1 | 99.0 | 101.8 | 81.4 | 81.4 | 93.7 | 70.9 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -464.3 | -444.0 | -468.1 | -393.7 | -357.2 | -281.6 | -246.7 | -234.1 | -211.1 | -180.1 | -148.7 | -115.0 | 56.4 | -60.1 | -41.4 | |
| Comprehensive Income | -30.6 | -36.1 | -24.0 | -31.3 | -15.1 | 0.0 | 0.0 | -12.0 | -9.3 | -6.8 | -5.4 | -4.0 | -2.8 | -1.8 | -1.1 | |
| Total Common Equity | 1,132.5 | 1,176.0 | 1,044.1 | 1,075.2 | 1,096.5 | 421.2 | 239.5 | 79.8 | 37.2 | 59.6 | 51.3 | 41.4 | 56.4 | 4.9 | 8.5 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Retained Earnings | -418.8 | -437.9 | -436.9 | -444.0 | -449.1 | -464.3 | -470.0 | -470.0 | -468.1 | -439.8 | |
| Comprehensive Income | -8.2 | -12.0 | -28.6 | -36.1 | -21.3 | -30.6 | -28.9 | -28.9 | -24.0 | -34.2 | |
| Total Common Equity | 1,257.7 | 1,221.1 | 1,194.9 | 1,176.0 | 1,176.0 | 1,132.5 | 1,118.6 | 1,118.6 | 1,044.1 | 1,054.1 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 20.7 | 50.7 | 12.6 | 14.7 | 18.9 | 12.3 | 13.6 | 25.3 | 25.2 | 25.5 | 5.0 | 4.9 | 4.9 | 0.0 | 0.0 | |
| Book Value | 1,132.5 | 1,176.0 | 1,044.1 | 1,075.2 | 1,096.5 | 421.2 | 239.5 | 79.8 | 37.2 | 59.6 | 51.3 | 41.4 | 56.4 | 4.9 | 8.5 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 1,257.7 | 1,221.1 | 1,194.9 | 1,176.0 | 1,176.0 | 1,132.5 | 1,118.6 | 1,118.6 | 1,044.1 | 1,054.1 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -54.0 | 66.4 | 24.1 | -74.4 | -36.6 | -75.6 | -34.9 | -12.6 | -23.0 | -31.0 | -31.4 | -33.7 | -29.4 | -25.6 | -18.6 | -14.4 | |
| Depreciation & Amortization | 25.0 | 21.4 | 23.5 | 27.2 | 25.9 | 19.6 | 7.9 | 4.1 | 3.9 | 3.8 | 3.5 | 2.3 | 1.2 | 1.0 | 0.7 | 0.6 | |
| Stock-Based Compensation | 32.6 | 43.6 | 36.2 | 33.1 | 26.7 | 22.5 | 13.0 | 9.8 | 6.0 | 6.6 | 6.4 | 5.6 | 3.5 | 1.2 | 0.9 | 0.7 | |
| Change Working Capital | -17.2 | -2.3 | -21.3 | -4.2 | -16.4 | 4.2 | -0.5 | -4.8 | -0.7 | -5.4 | -6.4 | 0.6 | -0.9 | 4.3 | 12.3 | -0.1 | |
| Change In Accounts Receivable | -8.0 | -0.7 | -6.4 | 3.9 | 1.1 | -8.6 | 1.0 | -6.2 | -0.5 | -4.0 | -5.3 | -0.6 | -2.0 | -0.7 | -0.6 | -0.5 | |
| Change In Accounts Payable | -2.6 | -1.0 | -4.3 | -0.1 | 0.2 | 5.2 | 0.7 | -0.1 | -1.6 | 1.7 | -1.4 | -3.5 | 1.9 | 3.3 | 1.3 | 0.1 | |
| Change In Inventories | -7.7 | -2.9 | -5.9 | -1.7 | -3.0 | -1.5 | 1.1 | -3.4 | 1.9 | -1.8 | 0.3 | -0.1 | -1.1 | -1.5 | -0.8 | -0.1 | |
| Other Non-cash Items | 123.4 | 7.8 | 12.8 | 66.3 | 7.7 | 3.9 | 2.7 | 0.3 | 0.3 | 2.1 | -0.2 | -1.8 | -2.1 | -0.3 | -2.7 | -0.7 | |
| Cash from Operations | 50.3 | 0.0 | 0.0 | 44.2 | 7.5 | -31.6 | -9.7 | -3.2 | -13.5 | -23.9 | -28.0 | -27.0 | -27.6 | -19.2 | -7.2 | -13.5 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 49.2 | 19.1 | -1.0 | 7.0 | 5.1 | 15.2 | 5.7 | -1.9 | -1.9 | -28.3 | |
| Depreciation & Amortization | 5.3 | 5.3 | 5.5 | 5.4 | 6.3 | 5.9 | 5.7 | 5.6 | 5.6 | 6.3 | |
| Stock-Based Compensation | 10.9 | 10.8 | 11.0 | 11.0 | 9.6 | 8.7 | 9.9 | 8.0 | 8.0 | 7.5 | |
| Change Working Capital | 5.5 | 6.4 | 1.2 | -15.4 | -4.2 | -0.1 | 5.8 | -22.8 | -22.8 | 1.4 | |
| Change In Accounts Receivable | 3.2 | 0.4 | 2.8 | -7.1 | 2.0 | 1.7 | -3.6 | -6.5 | -6.5 | -0.8 | |
| Change In Accounts Payable | -0.5 | -3.7 | -4.0 | 7.1 | -1.4 | -1.2 | -0.2 | -1.5 | -1.5 | -0.3 | |
| Change In Inventories | -0.2 | 0.2 | -0.6 | -2.3 | -1.7 | -0.9 | -1.0 | -2.3 | -2.3 | -0.1 | |
| Other Non-cash Items | -17.7 | 3.3 | 16.8 | -2.6 | 8.0 | 0.3 | 2.3 | 2.2 | 31.7 | 31.6 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -9.0 | 15.6 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -10.2 | -9.7 | -11.3 | -10.0 | -8.5 | -5.4 | -2.8 | -2.8 | -1.9 | -1.8 | -4.2 | -6.2 | -2.0 | -1.3 | -1.5 | -0.3 | |
| Acquisitions | 30.1 | -2.8 | 5.0 | 0.0 | 0.0 | -736.8 | 0.0 | -40.0 | 0.0 | 0.0 | 0.0 | 0.0 | -6.9 | 0.0 | 0.0 | 0.0 | |
| Investments | 0.0 | -150.0 | -50.0 | -19.7 | -33.5 | 162.4 | -1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 0.0 | 153.3 | 0.0 | 44.8 | 12.7 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | -25.1 | 0.0 | 0.0 | 0.0 | 0.0 | -162.4 | 0.0 | 0.0 | 0.0 | 0.6 | 0.0 | -0.5 | -0.1 | 0.1 | 0.0 | -0.1 | |
| Cash from Investing | -5.2 | 0.0 | 0.0 | 15.1 | -29.4 | -739.2 | -3.8 | -42.7 | -1.9 | -1.2 | -4.2 | -6.7 | -9.0 | -1.3 | -1.5 | -0.3 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -3.8 | -2.8 | -1.3 | -1.8 | -4.1 | -2.2 | -2.8 | -2.1 | -2.1 | -2.5 | |
| Acquisitions | -2.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.0 | 5.0 | 25.1 | |
| Investments | -50.0 | 0.0 | -50.0 | -50.0 | -50.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 51.2 | 51.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -25.1 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.9 | -2.5 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -4.3 | 0.0 | 0.0 | 0.0 | -1.3 | 0.0 | -0.1 | -25.2 | -0.3 | -27.2 | -5.3 | 0.0 | -0.1 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 10.2 | 50.7 | 38.1 | -2.1 | -2.9 | 6.5 | -1.2 | 13.5 | 0.3 | 26.9 | 25.8 | 0.1 | 0.1 | 4.9 | 0.0 | 0.0 | |
| Issuance of Common Stock | 8.6 | 0.0 | 0.0 | 9.6 | 7.9 | 593.8 | 193.8 | 137.8 | 55.0 | 0.2 | 31.9 | 37.3 | 10.1 | 66.3 | 0.0 | 0.0 | |
| Repurchase of Common Stock | -8.7 | 0.0 | 0.0 | -6.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | -7.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -9.3 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | -4.4 | 0.0 | 0.0 | 2.8 | -3.2 | 2.5 | 9.9 | 14.6 | 4.8 | 26.8 | 25.7 | 0.5 | -0.1 | 18.4 | 15.1 | 18.6 | |
| Cash from Financing | -0.1 | 0.0 | 0.0 | 2.8 | 3.5 | 596.3 | 203.6 | 127.3 | 59.5 | -0.2 | 52.3 | 37.7 | 0.4 | 77.7 | 15.1 | 18.6 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 40.5 | -10.2 | 0.1 | -0.2 | 31.0 | -1.0 | 6.7 | 14.0 | 1.4 | -1.1 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.0 | 1.8 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -3.8 | -1.1 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.9 | 0.6 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.9 | 0.6 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 44.8 | 123.6 | 23.3 | 62.3 | -19.0 | -176.0 | 190.0 | 81.3 | 44.1 | -25.3 | 20.1 | 4.1 | -36.2 | 57.2 | 6.4 | 4.8 | |
| Closing Cash Balance | 235.9 | 364.2 | 240.6 | 217.3 | 155.0 | 173.9 | 350.0 | 159.9 | 78.6 | 33.9 | 59.2 | 39.1 | 35.0 | 71.2 | 14.0 | 7.6 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 47.0 | 96.1 | 33.4 | -52.9 | -34.5 | 38.2 | 26.7 | -7.1 | -7.3 | 14.0 | |
| Closing Cash Balance | 364.2 | 315.6 | 221.2 | 187.8 | 240.6 | 275.2 | 237.0 | 210.3 | 209.2 | 216.5 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 40.1 | 126.6 | 63.8 | 34.3 | -1.0 | -37.0 | -12.5 | -6.0 | -15.4 | -25.7 | -32.2 | -33.1 | -29.7 | -20.5 | -8.6 | -13.8 | |
| Real Free Cash Flow | 7.5 | 83.0 | 27.6 | 1.1 | -27.7 | -59.5 | -25.5 | -15.8 | -21.4 | -32.3 | -38.6 | -38.7 | -33.2 | -21.7 | -9.6 | -14.5 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 48.3 | 42.0 | 32.3 | 3.5 | 20.4 | 27.7 | 26.8 | -11.1 | -11.1 | 13.1 | |
| Real Free Cash Flow | 37.4 | 31.2 | 21.3 | -7.4 | 10.8 | 19.0 | 17.0 | -19.1 | -19.1 | 5.5 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 39.1 | -29 | -1.4 |
| P/S | 5 | 8 | 9.4 |
| P/B | 2.1 | 6.3 | 5.2 |
| P/FCF | 31.4 | -19.5 | -1.5 |
| Market cap | $3.4 | $2.1 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 3 % | 10.5 % | 0 % |
| Debt to Income | 61 % | -41.3 % | 0 % |
| Debt to Free cash flow | 49 % | -218.6 % | 0 % |
| Interest expense percentage | 0 % | -3.7 % | 44.7 % |
| Current ratio | 6.2 | 6.1 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 5.3 % | -59 % | 0 % |
| ROA | 4.9 % | -22.6 % | 0 % |
| CapEx to Revenue | 2 % | 4.6 % | 0 % |
| RaD to Revenue | 0 % | 16.9 % | 0 % |
| ROEM | 627,603.2 | 265542.8 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 68.1 % | 60.3 % | 68.7 % |
| Operating margin | 5 % | -45.2 % | 35.5 % |
| Net margin | 6.1 % | -46.6 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 79.7 mil | 46.1 mil |
| Employee count | 0.8 tis | 0.4 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
